TOTAL ALLERGY CARE for HEALTH PROFESSIONALS
SIGN UP

Efficacy with Children’s ZYRTEC®

Children’s ZYRTEC® 5 mg makes a significant impact on allergy symptoms1*

A powerful symptom response in patients ages 2 to 6 years with seasonal allergic rhinitis (SAR)1

66% of children demonstrated ≥50% improvement from baseline SAR symptoms over 2 weeks.1

EFFICACY IN AGES 2 to 6

Children’s ZYRTEC® 10 mg makes a significant impact on allergy symptoms

Powerful symptom response also seen in patients ages 6 to 11 years with SAR1

Studies show 37% and 19% of children demonstrated ≥50% improvement from baseline SAR symptoms over 2 weeks.1

EFFICACY IN AGES 6 to 12

We know flavor matters

Children’s ZYRTEC® comes in kid-friendly flavors and formulations.

A story for caregivers to share with kids

Popular 2-part set helps families manage allergies. Available to download in English and Spanish.

*Randomized, placebo-controlled study of children aged 2 to 6 years with SAR during a 2-week period. Primary endpoint was the change in total symptom score complex from baseline.

†Significant vs placebo.

‡ZYRTEC® 5 mg vs placebo ratio at ≥50% reduction is 1.84-fold.

§Randomized, placebo-controlled studies of children aged 6 to 12 years with SAR during a 2-week period. Primary endpoint was the change in total symptom score complex from baseline.

||ZYRTEC® 10 mg vs placebo ratio at ≥50% reduction is 1.88-fold in Study 1 and 1.42-fold in Study 2.

References: 1. Data on file. Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division.